Hinrich Gronemeyer
7Patents
4h-index
15Co-inventors
50Inventor score
Filing activity: Jul 11, 1997 → Feb 28, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6699686B1 | Modified nuclear glucocorticoid receptor, fusion protein, and DNA fragments coding for said receptor and said fusion protein | Chemistry; Metallurgy | 23 | Expired |
| US6653322B1 | Therapeutic combinations of RAR antagonists and RXR agonists and use thereof | Human Necessities | 22 | Expired |
| US6130230A | Therapeutic combinations of RAR antagonists and RXR agonists and use thereof | Human Necessities | 16 | Expired |
| US6624154B1 | Compositions and methods for treatment of hyperproliferative diseases | Human Necessities | 5 | Expired |
| US6268173A | Polynucleotide encoding transcriptional intermediary factor-2 | Chemistry; Metallurgy | 2 | Expired |
| US6861508B2 | Transcriptional intermediary factor-2 | Chemistry; Metallurgy | 2 | Expired |
| US8338473B2 | Derivatives of psammaplin A, a method for their synthesis and their uses for the prevention or treatment of cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.